The analysis of competing events like cause-specific mortalitybeware of the Kaplan-Meier method

Nephrology Dialysis Transplantation

Volumn 26, Issue 1, 2011, Pages 56-61

  Verduijn, Marion ^a   Grootendorst, Diana C ^a   Dekker, Friedo W ^a   Jager, Kitty J ^b   Le Cessie, Saskia ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

cardiovascular mortality; epidemiology; KaplanMeier; survival analysis

Indexed keywords

ANALYTIC METHOD; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COHORT ANALYSIS; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; MORTALITY; PRIORITY JOURNAL;

CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CLINICAL TRIALS AS TOPIC; HUMANS; KAPLAN-MEIER ESTIMATE; SURVIVAL RATE;

EID: 78650632320     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq661     Document Type: Article

References (25)

1. Jager KJ, van Dijk PC, Zoccali C et al. The analysis of survival data: the Kaplan-Meier method. Kidney Int 2008; 74: 560-565
2. Southern DA, Faris PD, Brant R et al. Kaplan-Meier methods yielded misleading results in competing risk scenarios. J Clin Epidemiol 2006; 59: 1110-1114
3. Hermans MM, Brandenburg V, Ketteler M et al. Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int 2007; 72: 202-207
4. Bland JM, Altman DG. Survival probabilities (the Kaplan-Meier method). BMJ 1998; 317: 1572
5. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. New Engl J Med 1999; 341: 1725-1730
6. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York: John Wiley, 1980
7. Satagopan JM, Ben-Porat L, Berwick M et al. A note on competing risks in survival data analysis. Br J Cancer 2004; 91: 1229-1235
8. Van Dijk PC, Jager KJ, Stengel B et al. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000). Kidney Int 2005; 67: 1489-1499
9. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141-1154
10. van Dijk PC, Jager KJ, de Charro Fet al. Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant 2001; 16: 1120-1129
11. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med 2007; 26: 2389-2430
12. Tai BC, Machin D, White I et al. Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches. Stat Med 2001; 20: 661-684
13. Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics 1995; 51: 524-532
14. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509
15. Tripepi G, Jager KJ, Dekker FWet al. Bias in clinical research. Kidney Int 2008; 73: 148-153
16. Menon V, Wang X, Sarnak MJ et al. Long-term outcomes in nondia-betic chronic kidney disease. Kidney Int 2008; 73: 1310-1315
17. Derose SF, Rutkowski MP, Levin NW et al. Incidence of end-stage renal disease and death among insured African Americans with chronic kidney disease. Kidney Int 2009; 76: 629-637
18. Barbour SJ, Er L, Djurdjev O et al. Differences in progression of CKD and mortality amongst Caucasian, Oriental Asian and South Asian CKD patients. Nephrol Dial Transplant 2010; doi:10.1093/ndt/gfq189
19. Finne P, Reunanen A, Stenman S et al. Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA 2005; 294: 1782-1787
20. Sozio SM, Armstrong PA, Coresh J et al. Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study. Am J Kidney Dis 2009; 54: 468-477
21. Ferrari P, Lim W, Dent H et al. Effect of donor-recipient age difference on graft function and survival in live-donor kidney transplantation. Nephrol Dial Transplant 2010; doi:10.1093/ndt/gfq383
22. Evans DW, Ryckelynck JP, Fabre E et al. Peritonitis-free survival in peritoneal dialysis: an update taking competing risks into account. Nephrol Dial Transplant 2010; 25: 2315-2322
23. Johnson DW, Dent H, Hawley CM et al. Association of dialysis modality and cardiovascular mortality in incident dialysis patients. Clin J Am Soc Nephrol 2009; 4: 1620-1628
24. Johnson DW, Dent H, Hawley CM et al. Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand. Am J Kidney Dis 2009; 53: 290-297
25. Parekh RS, Plantinga LC, Kao WHL et al. The association of sudden cardiac death with inflammation and other traditional risk factors. Kidney Int 2008; 74: 1335-1342